DizzyFIX: Canadian Medical Technology Company Shows Steady Growth
CALGARY, ALBERTA–(Marketwire – Dec. 15, 2009) –
The DizzyFIX is the initial US Food and Drug Administration privileged healing device for the home diagnosis of Benign Paroxysmal Positional Vertigo (BPPV). BPPV is one of the heading causes of nausea which affects as many as 10 per cent of people over age 60. Prospective clinical trials have shown which the DizzyFIX is as in effect as physician-guided treatment.
The DizzyFIX was not long ago featured in the Dec emanate of Reader’s Digest repository where the diagnosis and diagnosis of nausea was discussed. “The DizzyFIX has been accessible to the tellurian marketplace place for over a year right away and we have been intensely unapproachable to have helped thousands of people who humour with vertigo in 68 countries in this short time period” pronounced Dr. Alp Sener, COO of Clearwater Clinical.
Clearwater Clinical (Calgary formed manufacturer of the DizzyFIX) has been demonstrating solid expansion over the past 6 buliding with the many brand brand new further of the Warsaw formed healing device distributor, EU MED. This outlines the 9th brand brand new general partnership over the past year. “Our one after another expansion attests to the worldwide need for correct diagnosis of BPPV and the application of this brand brand new device”, pronounced Sener. “In the stream time of mercantile hardship, the monetary weight of dear and ineffectual remedy to provide BPPV will hopefully turn a thing of the past. The DizzyFIX is the many affordable resolution for in effect diagnosis of Vertigo due to BPPV.”
